1. The Recombinant Protein Based on Trypanosoma cruzi P21 Interacts With CXCR4 Receptor and Abrogates the Invasive Phenotype of Human Breast Cancer Cells
   Bruna Cristina Borges et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
2. Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy
   Minghui Zhang et al, 2022, Cells CrossRef
3. CXCR4 knockdown enhances sensitivity of paclitaxel via the PI3K/Akt/mTOR pathway in ovarian carcinoma
   Dan Zi et al, 2022, Aging CrossRef
4. Enhanced CXCR4 Expression Associates with Increased Gene Body 5-Hydroxymethylcytosine Modification but not Decreased Promoter Methylation in Colorectal Cancer
   Alexei J. Stuckel et al, 2020, Cancers CrossRef
5. Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of Immunotherapy
   Anna Kasperska et al, 2021, Current Cancer Drug Targets CrossRef
6. Predictive and Prognostic Biomarkers for Lung Cancer Bone Metastasis and Their Therapeutic Value
   Xupeng Chai et al, 2021, Frontiers in Oncology CrossRef
7. CXCR4 and CXCR7 Signaling Pathways: A Focus on the Cross-Talk Between Cancer Cells and Tumor Microenvironment
   Sara Santagata et al, 2021, Frontiers in Oncology CrossRef
8. Chemokine signaling in cancer-stroma communications
   Arun J. Singh et al, 2021, Journal of Cell Communication and Signaling CrossRef
9. Intraovarian, Isoform-Specific Transcriptional Roles of Progesterone Receptor in Ovulation
   Kirsten M. Smith et al, 2022, Cells CrossRef